These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 35573146)

  • 21. Semiparametric Inference for ROC Curves with Censoring.
    Liang H; Zhou Y
    Scand Stat Theory Appl; 2008 Jun; 35(2):212-227. PubMed ID: 20300485
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nonparametric analysis of doubly truncated and interval-censored data.
    Shen PS
    Stat Methods Med Res; 2022 Jun; 31(6):1157-1170. PubMed ID: 35317692
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Maximum likelihood estimation for length-biased and interval-censored data with a nonsusceptible fraction.
    Shen PS; Peng Y; Chen HJ; Chen CM
    Lifetime Data Anal; 2022 Jan; 28(1):68-88. PubMed ID: 34623557
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Estimating correlation with multiply censored data arising from the adjustment of singly censored data.
    Newton E; Rudel R
    Environ Sci Technol; 2007 Jan; 41(1):221-8. PubMed ID: 17265951
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Double robust and efficient estimation of a prognostic model for events in the presence of dependent censoring.
    Schnitzer ME; Lok JJ; Bosch RJ
    Biostatistics; 2016 Jan; 17(1):165-77. PubMed ID: 26224070
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A mechanistic nonlinear model for censored and mismeasured covariates in longitudinal models, with application in AIDS studies.
    Zhang H; Wong H; Wu L
    Stat Med; 2018 Jan; 37(1):167-178. PubMed ID: 29034494
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A semiparametric regression cure model for doubly censored data.
    Wang P; Tong X; Sun J
    Lifetime Data Anal; 2018 Jul; 24(3):492-508. PubMed ID: 28864842
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Zero-truncated Poisson with Right Censoring: an Application to Translational Breast Cancer Research.
    Yeh HW; Gajewski B; Mukhopadhyay P; Behbod F
    Stat Biopharm Res; 2012 Aug; 4(3):252-263. PubMed ID: 23130093
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Doubly robust weighted log-rank tests and Renyi-type tests under non-random treatment assignment and dependent censoring.
    Li C
    Stat Methods Med Res; 2019 Sep; 28(9):2649-2664. PubMed ID: 29984622
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of censoring on learning Bayesian networks in survival modelling.
    Stajduhar I; Dalbelo-Basić B; Bogunović N
    Artif Intell Med; 2009 Nov; 47(3):199-217. PubMed ID: 19833488
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Parameter estimation of the incubation period of COVID-19 based on the doubly interval-censored data model.
    Yin MZ; Zhu QW; Lü X
    Nonlinear Dyn; 2021; 106(2):1347-1358. PubMed ID: 34177117
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Additive-multiplicative hazards regression models for interval-censored semi-competing risks data with missing intermediate events.
    Kim J; Kim J; Kim SW
    BMC Med Res Methodol; 2019 Mar; 19(1):49. PubMed ID: 30841923
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Distorted correlations among censored data: causes, effects, and correction.
    Barchard KA; Russell JA
    Behav Res Methods; 2024 Mar; 56(3):1207-1228. PubMed ID: 38129736
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Doubly robust inference procedure for relative survival ratio in population-based cancer registry data.
    Komukai S; Hattori S
    Stat Med; 2020 Mar; ():. PubMed ID: 32180235
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Simultaneous marginal survival estimators when doubly censored data is present.
    Julià O; Gómez G
    Lifetime Data Anal; 2011 Jul; 17(3):347-72. PubMed ID: 20886370
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inference of progressively type-II censored competing risks data from Chen distribution with an application.
    Ahmed EA; Ali Alhussain Z; Salah MM; Haj Ahmed H; Eliwa MS
    J Appl Stat; 2020; 47(13-15):2492-2524. PubMed ID: 35707419
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Semi-parametric hybrid empirical likelihood inference for two-sample comparison with censored data.
    Su H; Zhou M; Liang H
    Lifetime Data Anal; 2011 Oct; 17(4):533-51. PubMed ID: 21399910
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adjusted Empirical Likelihood Method in the Presence of Nuisance Parameters with Application to the Sharpe Ratio.
    Fu Y; Wang H; Wong A
    Entropy (Basel); 2018 Apr; 20(5):. PubMed ID: 33265407
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Bayesian MCMC approach to survival analysis with doubly-censored data.
    Yu B
    Comput Stat Data Anal; 2010 Aug; 54(8):1921-1929. PubMed ID: 20514348
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.